Clinical Trials List
2010-03-01 - 2012-12-31
Others
Terminated8
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- CHAO-CHI HO CHAO-CHI HO Division of Hematology & Oncology
- JIN-YUAN SHIH Division of Hematology & Oncology
- Chia-Chi Lin Division of Hematology & Oncology
- Chong-Jen Yu Division of Hematology & Oncology
- 林育麟 Division of Hematology & Oncology
- 陳冠宇 Division of Hematology & Oncology
- 廖唯昱 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 吳杰鴻 Division of Thoracic Medicine
- Jen-Fu Shih Division of Thoracic Medicine
- 范紋健 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- KUO-HSUAN HSU Division of Thoracic Medicine
- TSUNG -YING YANG Division of Thoracic Medicine
- 陳焜結 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Horng-Chyuan Lin Division of Thoracic Medicine
- Chih-Teng Yu Division of Thoracic Medicine
- Chih-Hung Chen Division of Thoracic Medicine
- Chih-Hung Chen Division of Thoracic Medicine
- Chun-Hua Wang Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Wen-Pin Su Division of Hematology & Oncology
- Yu-Min Yeh Division of Hematology & Oncology
- Ya-Ping Chen Division of Hematology & Oncology
- Peng-Chan Lin Division of Hematology & Oncology
- Chia-Jui Yen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chih-Jen Yang Division of Thoracic Medicine
- Jen-Yu Hung Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
49 participants
-
Global
170 participants
